Wide spectrum of presentation and variable mechanisms of compromised cardiac function in multiple organ dysfunction syndrome

References

• Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 1995; 27: 155–67
   Google Scholar
• Baue AE. MOF, MODS, and SIRS: what is in a name or an acronym?. Shock 2006; 26: 438–49
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Diabetologia 2004; 47: 1557–65
   PubMed Web of Science ®Google Scholar
• Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14: 589–600
   PubMed Web of Science ®Google Scholar
• Van den Berghe G. Insulin therapy for the critically ill patient. Clin Cornerstone 2003; 5: 56–63
   PubMedGoogle Scholar
• Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000; 11: 212–7
   PubMed Web of Science ®Google Scholar
• Grocott-Mason RM, Shah AM. Cardiac dysfunction in sepsis: new theories and clinical implications. Intensive Care Med 1998; 24: 286–95
   PubMed Web of Science ®Google Scholar
• Hoyer D, Frank B, Gotze C, Schmidt H, Baranowski R, Zebrowski JJ, et al. Complex autonomic dysfunction in cardiovascular, intensive care, and schizophrenic patients assessed by autonomic information flow. Biomed Tech (Berl) 2006; 51: 182–5
   Google Scholar
• Knuefermann P, Nemoto S, Baumgarten G, Misra A, Sivasubramanian N, Carabello BA, et al. Cardiac inflammation and innate immunity in septic shock: is there a role for toll-like receptors?. Chest 2002; 121: 1329–36
   PubMed Web of Science ®Google Scholar
• Von Korn H, Daniel WG, Nixdorff U. A rare cause of cardiomyopathy: the systemic inflammation response syndrome (SIRS). Heart 2001; 86: 362
   PubMed Web of Science ®Google Scholar
• Petaja LM, Sipponen JT, Hammainen PJ, Eriksson HI, Salmenpera MT, Suojaranta-Ylinen RT. Levosimendan reversing low output syndrome after heart transplantation. Ann Thorac Surg 2006; 82: 1529–31
   Google Scholar
• Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: myocardial depression in sepsis and septic shock. Crit Care 2002; 6: 500–8
   PubMed Web of Science ®Google Scholar
• McDonough KH, Smith T, Patel K, Quinn M. Myocardial dysfunction in the septic rat heart: role of nitric oxide. Shock 1998; 10: 371–6
   Google Scholar
• Ren J, Wu S. A burning issue: do sepsis and systemic inflammatory response syndrome (SIRS) directly contribute to cardiac dysfunction?. Front Biosci 2006; 11: 15–22
   PubMed Web of Science ®Google Scholar
• Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004; 109: 2058–67
   PubMed Web of Science ®Google Scholar
• Dybdahl B, Wahba A, Lien E, Flo TH, Waage A, Qureshi N, et al. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 2002; 105: 685–90
   PubMed Web of Science ®Google Scholar
• Yang LL, Gros R, Kabir MG, Sadi A, Gotlieb AI, Husain M, et al. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation 2004; 109: 255–61
   PubMed Web of Science ®Google Scholar
• Holm T, Aukrust P, Andreassen AK, Ueland T, Brosstad F, Froland SS, et al. Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines. Clin Transplant 2000; 14: 218–25
   Web of Science ®Google Scholar
• Parker MM. Myocardial dysfunction in sepsis: injury or depression?. Crit Care Med 1999; 27: 2035–6
   Google Scholar
• Parker MM. Pathophysiology of cardiovascular dysfunction in septic shock. New Horiz 1998; 6: 130–8
   Google Scholar
• Keller RS, Jones JJ, Kim KF, Myers PR, Adams HR, Parker JL, et al. Endotoxin-induced myocardial dysfunction: is there a role for nitric oxide?. Shock 1995; 4: 338–44
   Google Scholar
• Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR, et al. Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol 1997; 29: 1469–77
   PubMed Web of Science ®Google Scholar
• Ren J, Ren BH, Sharma AC. Sepsis-induced depressed contractile function of isolated ventricular myocytes is due to altered calcium transient properties. Shock 2002; 18: 285–8
   Google Scholar
• Powers FM, Farias S, Minami H, Martin AF, Solaro RJ, Law WR. Cardiac myofilament protein function is altered during sepsis. J Mol Cell Cardiol 1998; 30: 967–78
   Google Scholar
• Suffredini AF. Myocardial dysfunction in sepsis: clinical and experimental investigations. Schweiz Med Wochenschr 1998; 128: 1444–52
   Google Scholar
• Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704–11
   PubMed Web of Science ®Google Scholar
• Torre-Amione G, MacLellan W, Kapadia S, Weilbaecher D, Farmer J, Young J, et al. Tumor necrosis factor-alpha is persistently expressed in cardiac allografts in the absence of histological or clinical evidence of rejection. Transplant Proc 1998; 30: 875–7
   Google Scholar
• Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995; 96: 1042–52
   PubMed Web of Science ®Google Scholar
• Sigusch HH, Lehmann MH, Schnittler U, Reinhardt D, Figulla HR. Tumour necrosis factor-alpha expression in idiopathic dilated cardiomyopathy: correlation to myocardial inflammatory activity. Cytokine 2000; 12: 1261–6
   Google Scholar
• Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM. Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. J Card Fail 1997; 3: 117–24
   Google Scholar
• Pavlidis TE. Cellular changes in association with defense mechanisms in intra-abdominal sepsis. Minerva Chir 2003; 58: 777–81
   PubMedGoogle Scholar
• Caille V, Bossi P, Grimaldi D, Vieillard-Baro A. Physiopathology of severe sepsis. Presse Med 2004;33:256–61 (in French).
   Google Scholar
• Verma S, Wang CH, Weisel RD, Badiwala MV, Li SH, Fedak PW, et al. Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone. J Mol Cell Cardiol 2003; 35: 417–9
   Google Scholar
• Kou QY, Chen J, Ouyang B, Guan XD. Effect of continuous veno-venous hemofiltration on the plasma level of cytokines in patients with multiple organ dysfunction syndrome. Zhonghua Wai Ke Za Zhi 2006;44:1197–9 ( in Chinese).
   Google Scholar
• Hsu BG, Lee RP, Yang FL, Harn HJ, Chen HI. Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Sci 2006; 79: 2010–6
   PubMed Web of Science ®Google Scholar
• Sablotzki A, Dehne MG, Friedrich I, Grond S, Zickmann B, Muhling J, et al. Different expression of cytokines in survivors and non-survivors from MODS following cardiovascular surgery. Eur J Med Res 2003; 8: 71–6
   PubMed Web of Science ®Google Scholar
• Parratt JR. Nitric oxide in sepsis and endotoxaemia. J Antimicrob Chemother 1998; 41(Suppl A)31–9
   Google Scholar
• Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999; 43: 562–71
   PubMed Web of Science ®Google Scholar
• Esberg LB, Ren J. Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes. Diabetologia 2003; 46: 1419–27
   Google Scholar
• Saraiva RM, Hare JM. Nitric oxide signaling in the cardiovascular system: implications for heart failure. Curr Opin Cardiol 2006; 21: 221–8
   PubMed Web of Science ®Google Scholar
• Poon BY, Raharjo E, Patel KD, Tavener S, Kubes P. Complexity of inducible nitric oxide synthase: cellular source determines benefit versus toxicity. Circulation 2003; 108: 1107–12
   PubMed Web of Science ®Google Scholar
• Hare JM, Stamler JS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 2005; 115: 509–17
   PubMed Web of Science ®Google Scholar
• Lancel S, Tissier S, Mordon S, Marechal X, Depontieu F, Scherpereel A, et al. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J Am Coll Cardiol 2004; 43: 2348–58
   PubMed Web of Science ®Google Scholar
• Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 2000; 87: 241–7
   PubMed Web of Science ®Google Scholar
• Peng T, Lu X, Feng Q. Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression. Circulation 2005; 111: 1637–44
   PubMedGoogle Scholar
• Peterson TE, Katusic ZS. Transcribing the cross-talk of cytokine-induced tetrahydrobiopterin synthesis in endothelial cells. Circ Res 2005; 96: 141–3
   Google Scholar
• Auerbach G, Nar H. The pathway from GTP to tetrahydrobiopterin: three-dimensional structures of GTP cyclohydrolase I and 6-pyruvoyl tetrahydropterin synthase. Biol Chem 1997; 378: 185–92
   Google Scholar
• Hesslinger C, Kremmer E, Hultner L, Ueffing M, Ziegler I. Phosphorylation of GTP cyclohydrolase I and modulation of its activity in rodent mast cells. GTP cyclohydrolase I hyperphosphorylation is coupled to high affinity IgE receptor signaling and involves protein kinase C. J Biol Chem 1998; 273: 21616–22
   Google Scholar
• Huang A, Zhang YY, Chen K, Hatakeyama K, Keaney JF, Jr. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3. Circ Res 2005; 96: 164–71
   PubMed Web of Science ®Google Scholar
• Fitzal F, Redl H, Strohmaier W, Werner ER, Bahrami S. A 4-amino analogue of tetrahydrobiopterin attenuates endotoxin-induced hemodynamic alterations and organ injury in rats. Shock 2002; 18: 158–62
   Google Scholar
• Mittermayer F, Pleiner J, Schaller G, Zorn S, Namiranian K, Kapiotis S, et al. Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005; 289: H1752–7
   PubMed Web of Science ®Google Scholar
• Brahmbhatt S, Gupta A, Sharma AC. Bigendothelin-1 (1-21) fragment during early sepsis modulates tau, p38-MAPK phosphorylation and nitric oxide synthase activation. Mol Cell Biochem 2005; 271: 225–37
   PubMed Web of Science ®Google Scholar
• Gupta A, Aberle NS, Ren J, Sharma AC. Endothelin-converting enzyme-1-mediated signaling in adult rat ventricular myocyte contractility and apoptosis during sepsis. J Mol Cell Cardiol 2005; 38: 527–37
   Google Scholar
• Shindo T, Kurihara H, Kurihara Y, Morita H, Yazaki Y. Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model. J Cardiovasc Pharmacol 1998; 31(Suppl 1)S541–4
   Google Scholar
• Tanowitz HB, Huang H, Jelicks LA, Chandra M, Loredo ML, Weiss LM, et al. Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun 2005; 73: 2496–503
   PubMed Web of Science ®Google Scholar
• Yang LL, Arab S, Liu P, Stewart DJ, Husain M. The role of endothelin-1 in myocarditis and inflammatory cardiomyopathy: old lessons and new insights. Can J Physiol Pharmacol 2005; 83: 47–62
   PubMed Web of Science ®Google Scholar
• Shimojo N, Jesmin S, Zaedi S, Maeda S, Gando S, Yamaguchi I, et al. Alterations of gene expressions of preproET-1 and ET receptors in brains of endotoxemic Sprague-Dawley rats. Exp Biol Med (Maywood) 2006; 231: 1058–63
   Google Scholar
• Konrad D, Oldner A, Rossi P, Wanecek M, Rudehill A, Weitzberg E. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock. Crit Care Med 2004; 32: 1192–9
   Google Scholar
• Das UN. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 2000; 215: 145–52
   PubMed Web of Science ®Google Scholar
• Das UN. Metabolic syndrome X: an inflammatory condition?. Curr Hypertens Rep 2004; 6: 66–73
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111–9
   PubMed Web of Science ®Google Scholar
• Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes?. Diabetologia 2005; 48: 1038–50
   PubMed Web of Science ®Google Scholar
• Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Cardiovasc Drugs Ther 1994; 8: 65–73
   PubMed Web of Science ®Google Scholar
• Ren J, Bode AM. Altered cardiac excitation-contraction coupling in ventricular myocytes from spontaneously diabetic BB rats. Am J Physiol Heart Circ Physiol 2000; 279: H238–44
   Google Scholar
• Ren J, Ceylan-Isik AF. Diabetic cardiomyopathy: do women differ from men?. Endocrine 2004; 25: 73–83
   PubMed Web of Science ®Google Scholar
• Fang CX, Dong F, Ren BH, Epstein PN, Ren J. Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARgamma and c-Jun. Diabetologia 2005; 48: 2412–21
   PubMed Web of Science ®Google Scholar
• Brown RA, Anthony MJ, Petrovski P, Ren J. The influence of gender, diabetes, and acetaldehyde on the intrinsic contractile properties of isolated rat myocardium. Cardiovasc Toxicol 2001; 1: 35–42
   Google Scholar
• Ren J, Davidoff AJ. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 1997; 272: H148–58
   Google Scholar
• Ren J, Gintant GA, Miller RE, Davidoff AJ. High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner. Am J Physiol 1997; 273: H2876–83
   Google Scholar
• Norby FL, Aberle NS, Kajstura J, Anversa P, Ren J. Transgenic overexpression of insulin-like growth factor I prevents streptozotocin-induced cardiac contractile dysfunction and beta-adrenergic response in ventricular myocytes. J Endocrinol 2004; 180: 175–82
   Google Scholar
• Norby FL, Wold LE, Duan J, Hintz KK, Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab 2002; 283: E658–66
   Web of Science ®Google Scholar
• Jourdon P, Feuvray D. Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J Physiol 1993; 470: 411–29
   Google Scholar
• Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 1983; 244: E528–35
   PubMed Web of Science ®Google Scholar
• Dillmann WH. Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes 1980; 29: 579–82
   Google Scholar
• Liu X, Takeda N, Dhalla NS. Troponin I phosphorylation in heart homogenate from diabetic rat. Biochim Biophys Acta 1996; 1316: 78–84
   Google Scholar
• Akella AB, Ding XL, Cheng R, Gulati J. Diminished Ca2+ sensitivity of skinned cardiac muscle contractility coincident with troponin T-band shifts in the diabetic rat. Circ Res 1995; 76: 600–6
   Google Scholar
• Relling DP, Esberg LB, Fang CX, Johnson WT, Murphy EJ, Carlson EC, et al. High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis. J Hypertens 2006; 24: 549–61
   PubMed Web of Science ®Google Scholar
• Kim JA, Yeh DC, Ver M, Li Y, Carranza A, Conrads TP, et al. Phosphorylation of SER 24 in the PH domain of IRS-1 by mPLK/IRAK: cross-talk between inflammatory signaling and insulin signaling that may contribute to insulin resistance. J Biol Chem 2005; 280: 23173–83
   Google Scholar
• El Achkar TM, Dagher PC. Renal Toll-like receptors: recent advances and implications for disease. Nat Clin Pract Nephrol 2006; 2: 568–81
   Google Scholar
• Tavener SA, Kubes P. Cellular and molecular mechanisms underlying LPS-associated myocyte impairment. Am J Physiol Heart Circ Physiol 2006; 290: H800–6
   Google Scholar
• Tavener SA, Kubes P. Is there a role for cardiomyocyte toll-like receptor 4 in endotoxemia?. Trends Cardiovasc Med 2005; 15: 153–7
   Google Scholar
• Binck BW, Tsen MF, Islas M, White DJ, Schultz RA, Willis MS, et al. Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shock. Am J Physiol Heart Circ Physiol 2005; 288: H577–83
   Google Scholar
• Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 1998; 273: 12203–9
   PubMed Web of Science ®Google Scholar
• Janssens S, Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell 2003; 11: 293–302
   PubMed Web of Science ®Google Scholar
• Janssens S, Beyaert R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem Sci 2002; 27: 474–82
   PubMed Web of Science ®Google Scholar
• Bannerman DD, Tupper JC, Erwert RD, Winn RK, Harlan JM. Divergence of bacterial lipopolysaccharide pro-apoptotic signaling downstream of IRAK-1. J Biol Chem 2002; 277: 8048–53
   Google Scholar
• Deyerle KL, Sims JE, Dower SK, Bothwell MA. Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J Immunol 1992; 149: 1657–65
   PubMed Web of Science ®Google Scholar
• Frantz S, Kelly RA, Bourcier T. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biol Chem 2001; 276: 5197–203
   PubMed Web of Science ®Google Scholar
• Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, Hiramori K. Toll-like receptor 4 is expressed with enteroviral replication in myocardium from patients with dilated cardiomyopathy. Lab Invest 2004; 84: 173–81
   Google Scholar
• Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195: 99–111
   PubMed Web of Science ®Google Scholar
• Vabulas RM, Wagner H, Schild H. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 2002; 270: 169–84
   PubMed Web of Science ®Google Scholar
• Ramirez Cruz NE, Maldonado BC, Cuevas Uriostegui ML, Castanon J, Lopez MC, Isibasi A. Toll-like receptors: dysregulation in vivo in patients with acute respiratory distress syndrome. Rev Alerg Mex 2004; 51: 210–7
   Google Scholar
• Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological “damage limitation” effect and an important potential opportunity for therapy. Curr Med Chem 2006; 13: 2487–502
   PubMed Web of Science ®Google Scholar
• Podgoreanu MV, White WD, Morris RW, Mathew JP, Stafford-Smith M, Welsby IJ, et al. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation 2006; 114(1 Suppl)I275–81
   Google Scholar
• Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J, et al. Suicidal erythrocyte death in sepsis. J Mol Med 2006; Dec 16 [Epub ahead of print].
   Google Scholar
• Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 2000; 97: 1784–9
   PubMed Web of Science ®Google Scholar
• Chiao CW, Lee SS, Wu CC, Su MJ. Thaliporphine increases survival rate and attenuates multiple organ injury in LPS-induced endotoxaemia. Naunyn Schmiedebergs Arch Pharmacol 2005; 371: 34–43
   Google Scholar
• Ramana KV, Willis MS, White MD, Horton JW, DiMaio JM, Srivastava D, et al. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 2006; 114: 1838–46
   PubMed Web of Science ®Google Scholar